Hydroxyethyl Starch (HES) [130/0.4], a New HES Specification: Pharmacokinetics and Safety after Multiple Infusions of 10% Solution in Healthy Volunteers

By Waitzinger J.  

Drugs in R&D, Vol. 4, Iss. 3, 2003-01 ,pp. : 149-157

Adis International

Access to resources Recommend Favorite

Effect of a New Hydroxyethyl Starch (HES) Specification [6% HES (130/0.4)] on Blood and Plasma Volumes after Bleeding in 12 Healthy Male Volunteers

By Waitzinger J.  

Clinical Drug Investigation, Vol. 17, Iss. 2, 1999-02 ,pp. : 119-125

Adis International

Access to resources Recommend Favorite

Tissue Storage of 14 C-Labelled Hydroxyethyl Starch (HES) 130/0.4 and HES 200/0.5 after Repeated Intravenous Administration to Rats

By Leuschner J.  

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 331-338

Adis International

Access to resources Recommend Favorite

Single-dose pharmacokinetics and dose proportionality of intravenous pazufloxacin mesilate in healthy Korean volunteers

By Lee Joomi   Seong Sook Jin   Lim Mi-sun   Park Sung Min   Park Jeonghyeon   Seo Jeong Ju   Lee Hae Won   Yoon Young-Ran  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 8, 2012-08 ,pp. : 921-928

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors

By Wang Xian-Huo   Zhou Shi-Yong   Qian Zheng-Zi   Zhang Hui-Lai   Qiu Li-Hua   Song Zheng   Zhao Jing   Wang Ping   Hao Xi-Shan   Wang Hua-Qing  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 2, 2013-02 ,pp. : 117-125

Informa Healthcare

Access to resources Recommend Favorite